Premium
Effects of (+)‐pentazocine and 1,3‐di‐o‐tolylguanidine (DTG), sigma (σ) ligands, on micturition in anaesthetized rats
Author(s) -
Shimizu Isao,
Kawashima Katsuyoshi,
Ishii Daisuke,
Oka Makoto
Publication year - 2000
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/sj.bjp.0703593
Subject(s) - pentazocine , urination , cystometry , chemistry , (+) naloxone , stimulation , morphine , urinary bladder , pharmacology , anesthesia , endocrinology , medicine , urinary system , receptor , opioid , biochemistry
The effects of two sigma (σ) binding site ligands, (+)‐pentazocine and 1,3‐di‐ o ‐tolylguanidine (DTG), on bladder functions were examined in rats. Cystometry using urethane‐anaesthetized rats showed that (+)‐pentazocine (1–5 mg kg −1 , i.v.) and DTG (1–5 mg kg −1 , i.v.) prolonged micturition intervals, indicating increased bladder capacity and raised the threshold pressure. The effects of (+)‐pentazocine (2 mg kg −1 , i.v.) on micturition were not influenced by naloxone (0.5 mg kg −1 , i.v.), which antagonized similar effects of morphine (2 mg kg −1 , i.v.). When administered intracerebroventricularly (i.c.v.), DTG (1 μg) and (+)‐pentazocine (30 μg) prolonged micturition intervals with increased threshold pressure on the cystometrogram. In isolated bladder detrusor strips of rats, (+)‐pentazocine (3 μ M ) and DTG (1 μ M ) did not affect contractile responses to electrical field stimulation. A higher concentration of DTG (3 μ M ) slightly suppressed the response induced by 30 Hz stimulation. The effects of (+)‐pentazocine and DTG on micturition were abolished by pre‐treatment with pertussis toxin (PTX, 1 μg, i.c.v.). These results indicate that typical σ ligands, such as (+)‐pentazocine and DTG, increase bladder capacity in anaesthetized rats. Moreover, the mechanism by which σ ligands change the urinary storage properties in rats may involve pathways in which the function of Gi/o proteins is necessary.British Journal of Pharmacology (2000) 131 , 610–616; doi: 10.1038/sj.bjp.0703593